RASSF1 and neoplasm: In conclusion, this is the first study to examine epigenetic changes in a tumour suppressor gene, RASSF1A, the promoter of which is hypermethylated at a high frequency in neuroblastoma tumours, using serum DNA in a cohort of neuroblastoma patients.